Characterization of CCX140-B, an orally bioavailable antagonist of the CCR2 chemokine receptor, for the treatment of type 2 diabetes and associated complications.
- DOI
- 10.1124/jpet.111.190918
- Published
- 2012 Jun 5
- Container
- The Journal of pharmacology and experimental therapeutics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1124/jpet.111.190918,
title = {Characterization of CCX140-B, an orally bioavailable antagonist of the CCR2 chemokine receptor, for the treatment of type 2 diabetes and associated complications.},
author = {Sullivan TJ and Dairaghi DJ and Krasinski A and Miao Z and Wang Y and Zhao BN and Baumgart T and Berahovich R and Ertl LS and Pennell A and Seitz L and Miao S and Ungashe S and Wei Z and Johnson D and Boring L and Tsou CL and Charo IF and Bekker P and Schall TJ and Jaen JC},
year = {2012},
journal = {The Journal of pharmacology and experimental therapeutics},
doi = {10.1124/jpet.111.190918},
url = {https://doi.org/10.1124/jpet.111.190918}
}RIS
TY - JOUR TI - Characterization of CCX140-B, an orally bioavailable antagonist of the CCR2 chemokine receptor, for the treatment of type 2 diabetes and associated complications. AU - Sullivan TJ AU - Dairaghi DJ AU - Krasinski A AU - Miao Z AU - Wang Y AU - Zhao BN AU - Baumgart T AU - Berahovich R AU - Ertl LS AU - Pennell A AU - Seitz L AU - Miao S AU - Ungashe S AU - Wei Z AU - Johnson D AU - Boring L AU - Tsou CL AU - Charo IF AU - Bekker P AU - Schall TJ AU - Jaen JC PY - 2012 JO - The Journal of pharmacology and experimental therapeutics DO - 10.1124/jpet.111.190918 UR - https://doi.org/10.1124/jpet.111.190918 ER -
APA
TJ, S., DJ, D., A, K., Z, M., Y, W., BN, Z., T, B., R, B., LS, E., A, P., L, S., S, M., S, U., Z, W., D, J., L, B., CL, T., IF, C., P, B., TJ, S., & JC, J. (2012). Characterization of CCX140-B, an orally bioavailable antagonist of the CCR2 chemokine receptor, for the treatment of type 2 diabetes and associated complications.. The Journal of pharmacology and experimental therapeutics. https://doi.org/10.1124/jpet.111.190918
Source records
- pubmed · retrieved 2026-09-25T13:03:31.371Z